Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems

被引:3
|
作者
Ben Slama, Sana [1 ]
Ben Ghachem, Dorra [2 ]
Dhaoui, Amen [2 ]
Jomni, Mohamed Taieb [3 ]
Dougui, Mohamed Hedi [3 ]
Bellil, Khadija [2 ]
机构
[1] Hop M Slim La Marsa, Serv Anat Pathol, 2046 Sidi Daoud, Tunis, Tunisia
[2] Hop FSI La Marsa, Serv Anat Pathol, La Marsa, Tunisia
[3] Hop FSI La Marsa, Serv Gastroenterol, La Marsa, Tunisia
来源
关键词
Chronic gastritis; helicobacter pylori; atrophic gastritis; intestinal metaplasia; staging;
D O I
10.11604/pamj.2016.23.28.8839
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Helicobacter pylori (H pylori) gastritis presents a risk of cancer related to atrophy and intestinal metaplasia. Two recent classifications OLGA (Operative Link on Gastritis Assessment) and OLGIM (Operative Link on Gastritic Intestinal Metaplasia assessment) have been proposed to identify high-risk forms (stages III and IV). The aim of this study is to evaluate the OLGA and OLGIM staging systems in H pylori gastritis. A descriptive study of 100 cases of chronic H pylori gastritis was performed. The revaluation of Sydney System parameters of atrophy and intestinal metaplasia, of gastric antrum and corpus, allowed identifying respectively the stages of OLGA and OLGIM systems. The progressive risk of our H pylori gastritis was 6% according to OLGA staging and 7% according to OLGIM staging. Significant correlation was revealed between age and OLGA staging. High-risk gastritis according to OLGIM staging was significantly associated with moderate to severe atrophy. High-risk forms according to OLGA staging were associated in 80% of the cases to intestinal metaplasia. OLGA and OLGIM systems showed a highly significant positive correlation between them with a mismatch at 5% for H pylori gastritis. The OLGA and OLGIM staging systems in addition to Sydney System, allow selection of high risk forms of chronic gastritis requiring accurate observation.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [21] H. pylori chronic gastritis: OLGA and OLGIM evaluation and serum biomarkers for risk assessment of gastric cancer development in Brazilian patients
    Coelho, M.
    Ribeiro, H. G.
    Alves, J. S.
    Gomes, C. G.
    Ramos, A. P.
    Marinho, F. P.
    Lima, K. S.
    Passos, R. I.
    Barbosa, A. J. A.
    Coelho, L. G.
    HELICOBACTER, 2020, 25 : 51 - 51
  • [22] COMBINATION OF HELICOBACTER PYLORI STATUS AND SERUM PEPSINOGEN I/II RATIO AND OLGA/OLGIM STAGING FOR PREDICTION OF GASTRIC CANCER AND DYSPLASIA IN SOUTH KOREA
    Kim, Nayoung
    Baek, Sung Min
    Kwon, Young Jae
    Lee, Dong Ho
    GASTROENTEROLOGY, 2019, 156 (06) : S518 - S519
  • [23] The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study
    Beatriz E. Salazar
    Tania Pérez-Cala
    Sara Isabel Gomez-Villegas
    Laura Cardona-Zapata
    Sebastián Pazos-Bastidas
    Alejandra Cardona-Estepa
    Diego Enrique Vélez-Gómez
    José Armando Justinico-Castro
    Andrés Bernal-Cobo
    Harold Adrián Dávila-Giraldo
    Juan Carlos Benítez-Guerra
    Joaquín Tiberio Valencia-Cárdenas
    Edgar de Jesús Ospina
    Rodrigo Castaño-Llano
    María Mercedes Bravo
    Juan Carlos Cataño-Correa
    Jovanny Zabaleta
    Alba Alicia Trespalacios-Rangel
    Ana María Cock-Botero
    Miguel Ignacio Roldán-Pérez
    Alonso Martínez
    Virchows Archiv, 2022, 480 : 759 - 769
  • [24] OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy
    Saka, Akiko
    Yagi, Kazuyoshi
    Nimura, Satoshi
    DIGESTIVE ENDOSCOPY, 2015, 27 (07) : 734 - 741
  • [25] Gastritis staging in clinical practice: the OLGA staging system
    Rugge, Massimo
    Meggio, Alberto
    Pennelli, Gianmaria
    Piscioli, Francesco
    Giacomelli, Luciano
    De Pretis, Giovanni
    Graham, David Y.
    GUT, 2007, 56 (05) : 631 - 636
  • [26] Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging
    Rugge, Massimo
    Sugano, Kentaro
    Scarpignato, Carmelo
    Sacchi, Diana
    Oblitas, Walker Jove
    Naccarato, Antonio Giuseppe
    HELICOBACTER, 2019, 24 (02)
  • [27] OLGA Gastritis Staging - Predictor for Gastric Cancer?
    Martin, Kerstin
    Bajbouj, Monther
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (06): : 781 - 782
  • [28] OLGA Gastritis Staging & Intestinal Metaplasia Histochemistry
    Fassan, Matteo
    Pizzi, Marco
    Pennelli, Gianmaria
    Lazzarin, Vanni
    Balistreri, Mariangela
    Parente, Paola
    Clemente, Roberto
    Guzzardo, Vincenza
    Farinati, Fabio
    Rogge, Massimo
    GASTROENTEROLOGY, 2011, 140 (05) : S677 - S677
  • [29] Autoimmune gastritis: histology phenotype and OLGA staging
    Rugge, M.
    Fassan, M.
    Pizzi, M.
    Zorzetto, V.
    Maddalo, G.
    Realdon, S.
    DeBernard, M.
    Betterle, C.
    Cappellesso, R.
    Pennelli, G.
    de Boni, M.
    Farinati, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1460 - 1466
  • [30] Interobserver variation in histopathological assessment of Helicobacter pylori gastritis
    Ozlem Aydin
    Reyhan Egilmez
    Tuba Karabacak
    Arzu Kanik
    World Journal of Gastroenterology, 2003, 9 (10) : 2232 - 2235